title: Combination IL-2 and cisplatinum: a promising treatment for bronchioloalveolar carcinoma?
authors.forename: V
authors.initials: V
authors.lastname: Trillet-Lenoir
authors.forename: D
authors.initials: D
authors.lastname: Arpin
authors.forename: A
authors.initials: A
authors.lastname: Mercatello
authors.forename: R
authors.initials: R
authors.lastname: Oskham
authors.forename: P A
authors.initials: PA
authors.lastname: Palmer
authors.forename: P J
authors.initials: PJ
authors.lastname: Souquet
authors.forename: F
authors.initials: F
authors.lastname: Champel
authors.forename: J
authors.initials: J
authors.lastname: Boyer
authors.forename: J F
authors.initials: JF
authors.lastname: Cordier
authors.forename: C R
authors.initials: CR
authors.lastname: Franks
mesh_terms: D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000188:drug therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D005240:Feasibility Studies; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy*
chemical_list: D007376:Interleukin-2; D002945:Cisplatin